1. Home
  2. CMPS vs CRESY Comparison

CMPS vs CRESY Comparison

Compare CMPS & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • CRESY
  • Stock Information
  • Founded
  • CMPS 2020
  • CRESY 1936
  • Country
  • CMPS United Kingdom
  • CRESY Argentina
  • Employees
  • CMPS N/A
  • CRESY N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • CRESY Real Estate
  • Sector
  • CMPS Health Care
  • CRESY Finance
  • Exchange
  • CMPS Nasdaq
  • CRESY Nasdaq
  • Market Cap
  • CMPS 598.7M
  • CRESY 615.0M
  • IPO Year
  • CMPS 2020
  • CRESY 1997
  • Fundamental
  • Price
  • CMPS $5.31
  • CRESY $11.92
  • Analyst Decision
  • CMPS Strong Buy
  • CRESY
  • Analyst Count
  • CMPS 8
  • CRESY 0
  • Target Price
  • CMPS $16.43
  • CRESY N/A
  • AVG Volume (30 Days)
  • CMPS 2.1M
  • CRESY 291.9K
  • Earning Date
  • CMPS 11-04-2025
  • CRESY 11-10-2025
  • Dividend Yield
  • CMPS N/A
  • CRESY 4.99%
  • EPS Growth
  • CMPS N/A
  • CRESY N/A
  • EPS
  • CMPS N/A
  • CRESY 0.18
  • Revenue
  • CMPS N/A
  • CRESY $702,652,598.00
  • Revenue This Year
  • CMPS N/A
  • CRESY N/A
  • Revenue Next Year
  • CMPS N/A
  • CRESY N/A
  • P/E Ratio
  • CMPS N/A
  • CRESY $6.55
  • Revenue Growth
  • CMPS N/A
  • CRESY 31.80
  • 52 Week Low
  • CMPS $2.25
  • CRESY $8.39
  • 52 Week High
  • CMPS $7.09
  • CRESY $14.23
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 41.21
  • CRESY 61.51
  • Support Level
  • CMPS $5.01
  • CRESY $11.38
  • Resistance Level
  • CMPS $6.01
  • CRESY $12.06
  • Average True Range (ATR)
  • CMPS 0.47
  • CRESY 0.56
  • MACD
  • CMPS -0.09
  • CRESY -0.05
  • Stochastic Oscillator
  • CMPS 15.78
  • CRESY 50.00

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

Share on Social Networks: